Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease
Allergy
.
2024 Jan;79(1):232-234.
doi: 10.1111/all.15827.
Epub 2023 Jul 20.
Authors
Jochen Schmitt
1
,
Franz Ehm
1
,
Annika Vivirito
2
,
Danny Wende
3
,
Manuel Batram
4
,
Friedrich Loser
5
,
Simone Menzer
6
,
Marion Ludwig
2
,
Martin Roessler
3
,
Martin Seifert
1
,
Christina König
5
,
Claudia Schulte
3
,
Tilo Buschmann
7
,
Dagmar Hertle
3
,
Pedro Ballesteros
3
,
Stefan Baßler
7
,
Barbara Bertele
5
,
Thomas Bitterer
6
,
Cordula Riederer
8
,
Franziska Sobik
8
,
Barbara Kind
1
,
Susanne Abraham
9
,
Falko Tesch
1
Affiliations
1
Faculty of Medicine Carl Gustav Carus, Center for Evidence-Based Healthcare (ZEGV), TU Dresden, University Hospital, Dresden, Germany.
2
InGef-Institute for Applied Health Research GmbH Berlin, Berlin, Germany.
3
BARMER Institut für Gesundheitssystemforschung (bifg), Berlin, Germany.
4
Vandage GmbH, Bielefeld, Germany.
5
Techniker Krankenkasse, Hamburg, Germany.
6
IKK classic, Dresden, Germany.
7
AOK PLUS, Dresden, Germany.
8
DAK-Gesundheit, Hamburg, Germany.
9
Department of Dermatology Faculty of Medicine Carl Gustav Carus, University Allergy Center, TU Dresden, Dresden, Germany.
PMID:
37469301
DOI:
10.1111/all.15827
No abstract available
MeSH terms
COVID-19* / complications
COVID-19* / epidemiology
Cohort Studies
Dermatitis, Atopic* / epidemiology
Dermatitis, Atopic* / etiology
Humans
Risk Factors
Grants and funding
Bundesministerium für Gesundheit